文献速递衰弱、肌少症与跌倒老年慢病共病管理

未转诊肾移植的衰弱透析患者结局:一项队列研究

Outcomes for Frail Dialysis Patients Not Referred for Transplantation: A Cohort Study.
PubMed 文献 · J Am Geriatr Soc · 2026-05-29

该队列研究纳入2009至2018年401例未转诊肾移植的成人透析患者,用临床衰弱量表(CFS)评估衰弱严重度。CFS 6-8者90%死亡或出现永久移植禁忌,无一人接受移植;校正后CFS 4-5(HR 1.71,95%CI 1.17-2.21)和CFS 6-8(HR 2.34,95%CI 1.42-3.37)均与复合结局相关。

要点

  • 未转诊移植的透析患者中,CFS 6-8者90%死亡或出现永久移植禁忌,无人接受移植。
  • CFS 6-8者1年时27%发生死亡或永久移植禁忌,5年时升至81%。
  • 校正后CFS 4-5与CFS 6-8均与死亡或永久移植禁忌复合结局独立相关。

核心结论

  • 在未转诊肾移植的透析患者中,衰弱严重度越高,死亡或出现移植禁忌的风险越高,尤其在透析开始第一年后更明显。

研究设计与样本

  • 采用临床衰弱量表(CFS)评估衰弱并按严重度分类,用校正Cox比例风险回归模型分析至死亡或出现永久移植禁忌的时间。

主要发现

  • 401例患者中14%为CFS 6-8;CFS 6-8者90%死亡或出现永久移植禁忌,随访期间无人接受移植。
  • CFS 6-8者1年时27%死亡或出现永久移植禁忌,5年时升至81%。
  • 校正患者特征后,CFS 4-5与复合结局相关(HR 1.71,95%CI 1.17-2.21),CFS 6-8亦相关(HR 2.34,95%CI 1.42-3.37)。

关键数值与推荐

  • CFS 6-8者90%死亡或出现永久移植禁忌,无人接受移植。
  • CFS 6-8者1年时27%、5年时81%发生死亡或永久移植禁忌。
  • 校正后CFS 4-5的HR为1.71(95%CI 1.17-2.21),CFS 6-8的HR为2.34(95%CI 1.42-3.37)。

临床怎么用

  • 对未转诊移植的透析患者应评估衰弱严重度(CFS),高衰弱(CFS 6-8)提示死亡或移植禁忌风险高。
  • 透析开始后第一年应重点关注衰弱患者的结局变化,结合衰弱程度考虑移植转诊时机与支持策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Frailty is highly prevalent in kidney failure, but it is unclear whether frailty impacts health outcomes for those initiating dialysis who are not referred for transplantation. Our objective was to determine if frailty is associated with death or development of a permanent contraindication to transplantation among eligible non-referred patients following dialysis initiation. METHODS: We analyzed all incident adult dialysis patients from January 2009 to December 2018 (last follow-up December 2020) who lacked an identifiable absolute contraindication to transplant, but were not referred to our institution. Frailty was captured using the Clinical Frailty Scale (CFS) and categorized by severity. Time to death or development of a permanent contraindication to transplantation was analyzed using an adjusted Cox Proportional Hazards Regression model. Associations with the composite outcome were reported using hazard ratios (HR) and 95% confidence intervals (CI). RESULTS: A total of 401 patients were included, 14% had a CFS of 6-8; 90% of patients with CFS 6-8 either died or developed a permanent contraindication to transplant and none received a transplant during follow-up. Among patients with CFS 6-8, 27% died or developed a permanent contraindication at 1 year; increasing to 81% by 5 years. After adjusting for patient characteristics, frailty was associated with the composite outcome (CFS 4-5: HR 1.71, 95% CI 1.17-2.21; CFS 6-8: HR 2.34, 95% CI 1.42-3.37). CONCLUSIONS: Among patients not referred for transplantation, a higher frailty severity was associated with death or development of a contraindication, particularly after the first year following dialysis initiation. Future studies should explore whether alternative approaches to the timing of transplant referral in frail patients are associated with improved outcomes and focus on novel strategies to reduce frailty severity or better support frail patients who may otherwise be eligible for transplantation.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Goodwin J, Thorne J, Vinson A, et al. Outcomes for Frail Dialysis Patients Not Referred for Transplantation: A Cohort Study. J Am Geriatr Soc. 2026. PMID: 42212687. doi:10.1111/jgs.70496

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。